Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice

Blood Cancer Journal

Volumn 3, Issue 4, 2013, Pages

  Li, X ^a,b   Marcondes, A M ^a,c   Ragoczy, T ^a   Telling, A ^a   Deeg, H J ^a,c,d  

^a USA   (United States)

^b JIANGNAN UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Intravenous Route; Myelodysplastic Syndrome; Stroma Engraftment; Xenotransplantation

Indexed keywords

CD34 ANTIGEN;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; SCID MOUSE; STROMA CELL; TUMOR ENGRAFTMENT; XENOTRANSPLANTATION;

EID: 84878331820     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.11     Document Type: Article

References (34)

1. Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109-2117.
2. Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G et al. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. Int J Cancer 2008; 123: 2222-2227.
3. Kerbauy DMB, Lesnikov V, Torok-Storb B, Bryant E, Deeg HJ. Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID- b2microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells. Blood 2004; 104: 2202-2203.
4. Benito AI, Bryant E, Loken MR, Sale GE, Nash RA, Gass MJ et al. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk Res 2003; 27: 425-436.
5. Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 2000; 96: 2012-2021.
6. Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D et al. Involvement and functional impairment of the CD34CD38-Thy-1 hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259-267.
7. Raaijmakers MH, Scadden DT. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 2008; 15: 301-306.
8. Raaijmakers MHGP, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2012; 464: 852-857.
9. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002; 16: 1713-1724.
10. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 23-45.
11. Bhagat TD, Spaulding E, Sohal D, Mo Y, Marcondes M, Zhou L et al. 2008MDS marrow stroma is characterized by epigenetic alterations. Blood 112: 3635 (Abstract).
12. Mhyre A, Marcondes AM, Spaulding EY, Deeg HJ. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD. Blood 2009; 113: 649-658.
13. Li X, Marcondes AM, Gooley TA, Deeg HJ. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. Blood 2010; 116: 2304-2314.
14. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
15. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 1995; 85: 3636-3645.
16. Muguruma Y, Matsushita H, Yahata T, Yumino S, Tanaka Y, Miyachi H et al. Establishment of a xenograft model of human myelodysplastic syndromes. Haematologica 2011; 96: 543-551.
17. Graf L, Iwata M, Torok-Storb B. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood 2002; 100: 1509-1511.
18. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 1995; 85: 997-1005.
19. Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 1999; 145: 1119-1131.
20. Tormin A, Li O, Brune JC, Walsh S, Schutz B, Ehinger M et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011; 117: 5067-5077.
21. Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B. MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One 2010; 5: e14304.
22. Dolan ME, Pegg AE, Moschel RC, Vishnuvajjala BR, Flora KP, Grever MR et al. Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL. Cancer Chemother Pharmacol 1994; 35: 121-126.
23. Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C. Engraftment of NOD/SCID-b2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 2004; 103: 4285-4293.
24. Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 2010; 107: 21677-21682.
25. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998; 8: 43-55.
26. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I et al. Selfrenewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-336.
27. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
28. Ramakrishnan A, Torok-Storb BJ. The role of the marrow microenvironment in hematopoietic stem cell transplantation. Cell Ther Transplant 2010; 2: 7-12.
29. Takagi S, Saito Y, Hijikata A, Tanaka S, Watanabe T, Hasegawa T et al. Membranebound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 2012; 119: 2768-2777.
30. Kerbauy DMB, Mhyre A, Bryant E, Deeg HJ. Do MDS-derived clonal hematopoietic precursors require human stroma support for survival. Curr Res Hematol 2007; 1: 1-13.
31. Marcondes AM, Li X, Gooley TA, Milless B, Deeg HJ. Identification of DJ-1/Park-7 as a determinant of stroma-dependent and TNFa-induced apoptosis in MDS by using mass spectrometry and phosphopeptide analysis. Blood 2010; 115: 1993-2002.
32. Schanz J, Steidl C, Fonatsch C, Pfeilstocker M, Nosslinger T, Tuechler H et al. Coalesced multicentric analysis of 2351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J Clin Oncol 2011; 29: 1963-1970.
33. Akavia UD, Veinblat O, Benayahu D. Comparing the transcriptional profile of mesenchymal cells to cardiac and skeletal muscle cells. J Cell Physiol 2008; 216: 663-672.
34. Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 2011; 364: 2496-2506.